MedTrace Logo

Retrospective NIS to Evaluate the Patient Benefit of TES

NCT04983914 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2022-08-22

No results posted yet for this study

Summary

In this retrospective non-interventional study (NIS), the subjective and objective benefit of patients with retinitis pigmentosa (and other dystrophies like Usher, Choroideremia or cone-rod dystrophy), who have been prescribed the therapy of transcorneal electrostimulation (TcES) with the OkuStim System, is assessed.

Conditions

Interventions

DEVICE

Transcorneal Electrostimulation via OkuStim System

Transcorneal electrostimulation, usually applied once per week for 30 min (home-use).

Sponsors & Collaborators

  • CONET GmbH - Clinical Operations Network

    collaborator UNKNOWN

  • Okuvision GmbH

    lead INDUSTRY

Principal Investigators

  • Hendrik Scholl, Prof. Dr. · Department of Ophthalmology, University of Basel, Switzerland

  • Katarina Stingl, Prof. Dr. · University Eye Hospital Tuebingen, Tuebingen, Germany

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-06
Primary Completion
2022-08-19
Completion
2022-08-19

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04983914 on ClinicalTrials.gov